We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
MDRX vs. HMSY: Which Stock Should Value Investors Buy Now?
Read MoreHide Full Article
Investors interested in Medical Info Systems stocks are likely familiar with AllScripts Healthcare (MDRX - Free Report) and HMS Holdings . But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look.
We have found that the best way to discover great value opportunities is to pair a strong Zacks Rank with a great grade in the Value category of our Style Scores system. The Zacks Rank favors stocks with strong earnings estimate revision trends, and our Style Scores highlight companies with specific traits.
Right now, AllScripts Healthcare is sporting a Zacks Rank of #2 (Buy), while HMS Holdings has a Zacks Rank of #3 (Hold). This system places an emphasis on companies that have seen positive earnings estimate revisions, so investors should feel comfortable knowing that MDRX is likely seeing its earnings outlook improve to a greater extent. But this is just one factor that value investors are interested in.
Value investors also tend to look at a number of traditional, tried-and-true figures to help them find stocks that they believe are undervalued at their current share price levels.
Our Value category highlights undervalued companies by looking at a variety of key metrics, including the popular P/E ratio, as well as the P/S ratio, earnings yield, cash flow per share, and a variety of other fundamentals that have been used by value investors for years.
MDRX currently has a forward P/E ratio of 12.62, while HMSY has a forward P/E of 22.97. We also note that MDRX has a PEG ratio of 1.80. This popular figure is similar to the widely-used P/E ratio, but the PEG ratio also considers a company's expected EPS growth rate. HMSY currently has a PEG ratio of 2.30.
Another notable valuation metric for MDRX is its P/B ratio of 1.10. Investors use the P/B ratio to look at a stock's market value versus its book value, which is defined as total assets minus total liabilities. By comparison, HMSY has a P/B of 2.80.
These are just a few of the metrics contributing to MDRX's Value grade of B and HMSY's Value grade of C.
MDRX stands above HMSY thanks to its solid earnings outlook, and based on these valuation figures, we also feel that MDRX is the superior value option right now.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
MDRX vs. HMSY: Which Stock Should Value Investors Buy Now?
Investors interested in Medical Info Systems stocks are likely familiar with AllScripts Healthcare (MDRX - Free Report) and HMS Holdings . But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look.
We have found that the best way to discover great value opportunities is to pair a strong Zacks Rank with a great grade in the Value category of our Style Scores system. The Zacks Rank favors stocks with strong earnings estimate revision trends, and our Style Scores highlight companies with specific traits.
Right now, AllScripts Healthcare is sporting a Zacks Rank of #2 (Buy), while HMS Holdings has a Zacks Rank of #3 (Hold). This system places an emphasis on companies that have seen positive earnings estimate revisions, so investors should feel comfortable knowing that MDRX is likely seeing its earnings outlook improve to a greater extent. But this is just one factor that value investors are interested in.
Value investors also tend to look at a number of traditional, tried-and-true figures to help them find stocks that they believe are undervalued at their current share price levels.
Our Value category highlights undervalued companies by looking at a variety of key metrics, including the popular P/E ratio, as well as the P/S ratio, earnings yield, cash flow per share, and a variety of other fundamentals that have been used by value investors for years.
MDRX currently has a forward P/E ratio of 12.62, while HMSY has a forward P/E of 22.97. We also note that MDRX has a PEG ratio of 1.80. This popular figure is similar to the widely-used P/E ratio, but the PEG ratio also considers a company's expected EPS growth rate. HMSY currently has a PEG ratio of 2.30.
Another notable valuation metric for MDRX is its P/B ratio of 1.10. Investors use the P/B ratio to look at a stock's market value versus its book value, which is defined as total assets minus total liabilities. By comparison, HMSY has a P/B of 2.80.
These are just a few of the metrics contributing to MDRX's Value grade of B and HMSY's Value grade of C.
MDRX stands above HMSY thanks to its solid earnings outlook, and based on these valuation figures, we also feel that MDRX is the superior value option right now.